A recent study conducted by Australian researchers has revealed that more than a third of infants diagnosed with peanut allergies may not actually be allergic, offering new insights that could significantly relieve the burdens faced by families dealing with dietary restrictions.
:max_bytes(150000):strip_icc():format(jpeg)/Young-girl-spreading-peanut-butter-onto-a-piece-of-bread-110526-c93ec5dad53c4d2d8ab16325440b5c55.jpg)
The researchers from the Murdoch Children’s Research Institute (MCRI) and the National Allergy Centre of Excellence (NACE) assessed 778 infants under the age of 18 months who had already been diagnosed with peanut allergies. This investigation took place across ten paediatric hospitals and involved a method known as a supervised oral food challenge, wherein infants were progressively given increasing doses of peanuts under medical supervision to evaluate any potential allergic reactions.
The findings, which were published in The Journal of Allergy and Clinical Immunology: In Practice, indicated that 65% of the infants did experience a reaction to peanuts. However, remarkably, 35% showed no reaction at all, prompting their medical teams to deem them no longer allergic to peanuts.
Dr Tim Brettig, a senior research clinician with MCRI’s Population Allergy Group, stated that identifying children who do not have a true allergy early on could significantly spare them—and their families—from the challenges of navigating a strict avoidance of peanuts. “Being able to identify those children early allows them to avoid an unnecessary allergy label and the burden of avoiding peanut,” he explained.
The study highlights several individual cases, including that of a baby named Arthur, diagnosed with a peanut allergy at just five months old. After undergoing the supervised oral food challenge, Arthur showcased no allergic response, leading to the removal of his diagnosis. His mother, Leah, expressed relief and gratitude, noting the uncertainty that can accompany suspected allergies. “We were understandably anxious going into the challenge, because we didn’t know how Arthur would respond. It’s a huge relief knowing Arthur can tolerate peanut and we can move forward without the uncertainty of managing a suspected allergy,” she shared.
For those infants who did react during the challenge, nearly all commenced a course of immunotherapy. This treatment involves controlled exposure to small doses of peanuts to gradually increase the child’s tolerance over time. The ADAPT Peanut Oral Immunotherapy Program, which is coordinated by Dr Brettig, plays a significant role in this approach.
Professor Kirsten Perrett, an influential figure within MCRI’s Population Allergy Group and director at NACE, emphasised the importance of incorporating supervised oral food challenges as a standard step in the diagnosis process. “A supervised oral food challenge should be routinely considered to confirm the diagnosis before an infant starts oral immunotherapy,” she stated. Her comments reinforce a broader objective to lessen the difficulties associated with food allergies for children and families alike.
In alignment with this research, the American College of Allergy, Asthma & Immunology (ACAAI) has begun advocating for the early introduction of peanut-containing foods into infants’ diets. Contrary to previous guidelines that suggested delaying such introductions, recent findings now indicate that offering these foods at around four to six months can reduce the likelihood of developing peanut allergies later in life.
The significance of this study is profound, as it not only proposes a potential reevaluation of how peanut allergies are diagnosed in infants but also suggests a shift towards more proactive measures in managing food allergies. The findings are expected to influence future practices, as both parents and medical professionals weigh the benefits of early dietary exposure against the anxiety and uncertainties of food allergies.
With the rising patterns of food allergies observed globally, this research could mark a pivotal transition in allergy management for infants, ultimately leading to better quality of life and fewer dietary restrictions for children and their families.
About the Author
